Krzysztof S.
- Country
- Poland
- Department
- Oncology clinic clinical outpatient clinic
Research Overview
- Evaluation of BI 770371 and Pembrolizumab, With or Without Cetuximab, Versus Pembrolizumab Monotherapy in Head and Neck Squamous Cell Carcinoma Patients
- Evaluation of Lutetium (177Lu) Vipivotide Tetraxetan in Recurrent/Metastatic Adenoid Cystic Carcinoma of Salivary Glands: Safety and Tolerability Study
- AN OPEN-LABEL, MULTICENTER, GLOBAL PHASE II BASKET STUDY OF ENTRECTINIB FOR THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS THAT HARBOR NTRK1/2/3, ROS1, OR ALK GENE REARRANGEMENTS
Data & Insights
Has run more than one trial at 7 of 40 partner sites.
Specializations
Oncology & Nuclear Medicine
The investigator specializes in innovative therapeutic approaches for adenoid cystic carcinoma, particularly focusing on salivary gland manifestations. Their research explores the application of targeted radionuclide therapy using specialized prostate-specific membrane antigen markers.
- Salivary Gland Oncology
- Radioligand Therapy
- Metastatic Disease Management
Clinical expertise extends to the evaluation of novel therapeutic interventions for recurrent and metastatic conditions.
Therapeutic Assessment
The investigator conducts comprehensive evaluations of treatment effectiveness and safety profiles in advanced cancer therapies. Their work encompasses detailed monitoring of therapeutic responses and adverse events.
- Treatment Safety Assessment
- Therapeutic Tolerability
- Clinical Response Evaluation
Expertise includes systematic assessment of treatment outcomes using standardized criteria for adverse event monitoring.
Advanced Cancer Treatment
The investigator focuses on developing personalized treatment approaches for patients with complex oncological conditions. Their research emphasizes innovative solutions for challenging cancer presentations.
- Targeted Therapy Development
- Recurrent Cancer Management
- Novel Treatment Protocols
Special interest in the application of advanced therapeutic agents for treatment-resistant cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.